Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study - Reply

被引：0
|
作者：
Jenkins, V [1 ]
Bloomfield, D [1 ]
Shilling, V [1 ]
机构：
[1] Univ Sussex, Brighton & Sussex Med Sch, Psychosocial Oncol Grp, Canc Res UK, Brighton, E Sussex, England
来源：
BJU INTERNATIONAL | 2005年 / 96卷 / 06期
关键词：
D O I：
10.1111/j.1464-410X.2005.05841_6.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：918 / 919
页数：2
相关论文
共 50 条
  • [41] Does endocrine therapy for the treatment and prevention of breast cancer affect memory and cognition?
    Jenkins, Valerie
    Atkins, Louise
    Fallowfield, Lesley
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (09) : 1342 - 1347
  • [42] Neoadjuvant hormone therapy with radiotherapy for prostate cancer: Review of experimental and clinical observations
    Garzotto, M
    Fair, WR
    Heston, WDW
    MOLECULAR UROLOGY, 1998, 2 (03) : 129 - 133
  • [43] Comparing Eccentric Resistance Exercise in Prostate Cancer Survivors On and Off Hormone Therapy: A Pilot Study
    Hansen, Pamela A.
    Dechet, Christopher B.
    Porucznik, Christina A.
    LaStayo, Paul C.
    PM&R, 2009, 1 (11) : 1019 - 1024
  • [44] Re: Early Results of Unilateral Prostatic Artery Embolization as a Focal Therapy in Patients with Prostate Cancer under Active Surveillance: Cancer Prostate Embolization, a Pilot Study
    Balasubramanian, Adithya
    Nagar, Himanshu
    Barbieri, Christopher E.
    Tagawa, Scott T.
    McClure, Timothy D.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2021, 32 (08) : 1243 - 1244
  • [45] Re: Early Results of Unilateral Prostatic Artery Embolization as a Focal Therapy in Patients with Prostate Cancer Under Active Surveillance: Cancer Prostate Embolisation, a Pilot Study
    Schmid, Hans-Peter
    Hechelhammer, Lukas
    Mullhaupt, Gautier
    EUROPEAN UROLOGY, 2022, 81 (01) : 121 - 122
  • [46] A pilot 'window of opportunity' neoadjuvant study of metformin in localised prostate cancer
    Joshua, A. M.
    Zannella, V. E.
    Downes, M. R.
    Bowes, B.
    Hersey, K.
    Koritzinsky, M.
    Schwab, M.
    Hofmann, U.
    Evans, A.
    van der Kwast, T.
    Trachtenberg, J.
    Finelli, A.
    Fleshner, N.
    Sweet, J.
    Pollak, M.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2014, 17 (03) : 252 - 258
  • [47] A pilot ‘window of opportunity’ neoadjuvant study of metformin in localised prostate cancer
    A M Joshua
    V E Zannella
    M R Downes
    B Bowes
    K Hersey
    M Koritzinsky
    M Schwab
    U Hofmann
    A Evans
    T van der Kwast
    J Trachtenberg
    A Finelli
    N Fleshner
    J Sweet
    M Pollak
    Prostate Cancer and Prostatic Diseases, 2014, 17 : 252 - 258
  • [48] Withdrawal of hormone replacement therapy might affect multigene signature results in early luminal breast cancer
    Neven, P.
    Jongen, L.
    Van Asten, K.
    Berteloot, P.
    Floris, G.
    Wildiers, H.
    ANNALS OF ONCOLOGY, 2015, 26 (02) : 437 - 438
  • [49] Accelerated hypofractionated radiation therapy with neoadjuvant and concomitant hormone therapy for intermediate risk prostate cancer
    Yassa, M.
    Fortin, B.
    Fortin, M-A.
    Lambert, C.
    Nguyen, T. V.
    Bahary, J-P.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S439 - S439
  • [50] Accelerated hypofractionated radiation therapy with neoadjuvant and concomitant hormone therapy for intermediate risk prostate cancer
    Yassa, M.
    Fortin, B.
    Lambert, C.
    Nguyen, T.
    Fortin, M.
    Bahary, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S347 - S348
12345